Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoidfree immunosuppressive regimen, N Engl J Med, vol.343, issue.4, pp.230-238, 2000. ,
Five-year metabolic, functional, and safety results of patients with type 1 diabetes transplanted with allogenic islets within the Swiss-French GRAGIL Network, Diabetes Care, vol.38, issue.9, pp.1714-1722, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01850555
Early metabolic markers that anticipate loss of insulin independence in type 1 diabetic islet allograft recipients, Am J Transplant, vol.12, issue.5, pp.1275-1289, 2012. ,
Revascularization of transplanted islets: can it be improved?, Diabetes, vol.57, issue.9, pp.2269-2271, 2008. ,
Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation, Diabetes, vol.56, issue.8, pp.2008-2015, 2007. ,
Islet transplantation as a treatment for diabetes: a work in progress, N Engl J Med, vol.350, issue.7, pp.694-705, 2004. ,
An integrated view of beta-cell dysfunction in type-II diabetes, Annu Rev Med, vol.47, pp.69-83, 1996. ,
Acute insulin response to intravenous glucose, glucagon and arginine in some subjects at risk for type 1 (insulin-dependent) diabetes mellitus, Diabetologia, vol.34, issue.9, pp.648-654, 1991. ,
Improvement in b-cell secretory capacity after human islet transplantation according to the CIT07 protocol, Diabetes, vol.62, issue.8, pp.2890-2897, 2013. ,
Insulin sensitivity index in type 1 diabetes and following human islet transplantation: comparison of the minimal model to euglycemic clamp measures, Am J Physiol Endocrinol Metab, vol.306, issue.10, pp.1217-1224, 2014. ,
Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass, Diabetes, vol.47, issue.3, pp.324-330, 1998. ,
Early metabolic markers of islet allograft dysfunction, Transplantation, vol.87, issue.5, pp.689-697, 2009. ,
b-Cell function following human islet transplantation for type 1 diabetes, Diabetes, vol.54, issue.1, pp.100-106, 2005. ,
Successful islet transplantation: continued insulin reserve provides long-term glycemic control, Diabetes, vol.51, issue.7, pp.2148-2157, 2002. ,
Assessment of b-cell mass and a-and b-cell survival and function by arginine stimulation in human autologous islet recipients, Diabetes, vol.64, issue.2, pp.565-572, 2015. ,
Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index, J Clin Endocrinol Metab, vol.85, issue.11, pp.4396-4402, 2000. ,
Oral glucose tolerance test minimal model indexes of b-cell function and insulin sensitivity, Diabetes, vol.50, issue.1, pp.150-158, 2001. ,
Assessment of b-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests, Am J Physiol Endocrinol Metab, vol.293, issue.1, pp.1-15, 2007. ,
Meal and oral glucose tests for assessment of beta-cell function: modeling analysis in normal subjects, Am J Physiol Endocrinol Metab, vol.283, issue.6, pp.1159-1166, 2002. ,
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study, Diabetologia, vol.54, issue.6, pp.1507-1516, 2011. ,
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans, Diabetologia, vol.55, issue.5, pp.1346-1354, 2012. ,
Evaluation of insulin sensitivity and glucose effectiveness during a standardized breakfast test: comparison with the minimal model analysis of an intravenous glucose tolerance test, Metabolism, vol.55, issue.5, pp.676-690, 2006. ,
Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network, Transplantation, vol.92, issue.9, pp.1031-1038, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00628808
, Trial Comparing Metabolic Efficiency of Islet Graft to Intensive Insulin Therapy for Type 1 Diabetes's Treatment (TRIMECO), 2016.
Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium, Diabetologia, vol.44, issue.7, pp.859-864, 1999. ,
Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior, J Clin Endocrinol Metab, vol.51, issue.3, pp.520-528, 1980. ,
Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance, Diabetes, vol.41, issue.3, pp.368-377, 1992. ,
Quantitative estimation of insulin sensitivity, Am J Physiol, vol.236, issue.6, pp.667-677, 1979. ,
Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol, Diabetes, vol.50, issue.4, pp.710-719, 2001. ,
b-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants, J Clin Endocrinol Metab, vol.95, issue.3, pp.1238-1246, 2010. ,
Five-year follow-up after clinical islet transplantation, Diabetes, vol.54, issue.7, pp.2060-2069, 2005. ,
Type 1 Diabetes Trial Net Research GroupEuropean C-Peptide Trial Study Group. Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes, Diabetes Care, vol.31, issue.10, pp.1966-1971, 2008. ,
Insulin secretion rates estimated by two mathematical methods in pancreas-kidney transplant recipients, Am J Physiol, vol.274, issue.4, pp.716-725, 1998. ,
Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance. Diabetologia, vol.53, pp.749-756, 2010. ,